Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001415889-25-010079

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 947,804 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2025-04-01 Grant or award · Stock Option (right to buy) +473,902 473,902 D
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2025-04-01 Grant or award · Restricted Stock Units +473,902 473,902 D
Loading xslF345X05/form4-04032025_110445.xml…